4 programming-"https:"-"https:"-"https:"-"https:"-"https:"-"Data-driven-Materials-Modeling" positions at Sanquin Blood Supply Foundation (Sanquin) in Netherlands
-
for 300,000 patients each year. Gene therapy program Sanquin The gene therapy group within Sanquin focuses on further improvement of the quality of life of patients with hematological disorders. Within
-
with rare bleeding disorders are limited. In the context of the UNIBLEED program, we aim to develop a novel universal therapy for maintaining hemostasis in patients at risk for bleeding. Objectives
-
, multidisciplinary research program aimed at transforming our understanding of bleeding variability in congenital bleeding disorders (CBDs) and bleeding disorders of unknown cause (BDUC). Patients with similar
-
, an ambitious ERC-funded research program that aims to develop and evaluate personalized donor health protection strategies for blood and plasma donors. As demand for plasma-derived medicinal products continues